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We have previously shown that avian reovirus (ARV) jA and jNS proteins possess dsRNA and ssRNA binding activity and suggested
that there are two epitopes on jA (I and II) and three epitopes (A, B, and C) on jNS. To further define the location of epitopes on jA and
jNS proteins and to further elucidate the biological functions of these epitopes by using monoclonal antibodies (MAbs) 62, 1F9, H1E1, and
4A123 against the ARV S1133 strain, the full-length and deletion fragments of S2 and S4 genes of ARV generated by polymerase chain
reaction (PCR) were cloned into pET32 expression vectors and the fusion proteins were overexpressed in Escherichia coli BL21 strain.
Epitope mapping using MAbs and E. coli-expressed deletion fragments of jA and jNS of the ARV S1133 strain, synthetic peptides, and the
cross reactivity of MAbs to heterologous ARV strains demonstrated that epitope II on jA was located at amino acid residues
340QWVMAGLVSAA350 and epitope B on jNS at amino acid residues 180MLDMVDGRP188. The MAbs (62, 1F9, and H1E1) directed
against epitopes II and B did not require the native conformation of jA and jNS, suggesting that their binding activities were conformation-
independent. On the other hand, MAb 4A123 only reacted with complete jNS but not with truncated jNS fusion proteins in Western blot,
suggesting that the binding activity of MAb to epitope A on jNS was conformation-dependent. Amino acid sequence analysis and the
binding assays of MAb 62 to heterologous ARV strains suggested that epitope II on jAwas highly conserved among ARV strains and that
this epitope is suitable as a serological marker for the detection of ARVantibodies following natural infection in chickens. On the contrary, an
amino acid substitution at position 183 (M to V) in epitope B of ARV could hinder the reactivity of the jNS with MAb 1F9. The jNS of
ARV with ssRNA-binding activity could be blocked by monoclonal antibody 1F9. The epitope B on jNS is required for ssRNA binding
because its deletion fully abolished the ssRNA binding activity of jNS.
D 2004 Elsevier Inc. All rights reserved.
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activityIntroduction
Avian reovirus (ARV) and mammalian reovirus (MRV)
belong to the genus Orthoreovirus. Both share physical–
chemical and morphological characteristics, including seg-
mented genomes consisting of 10 genome segments of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 The first two authors contributed equally to this study.double-stranded (ds) RNA. The RNA is packaged into a non-
enveloped icosahedral double capsid (Spandidos and Gra-
ham, 1976). The genomic segments can be separated by
polyacrylamide gel electrophoresis (PAGE) into three size
classes, large (L), medium (M), and small (S). However,
ARV differs from its mammalian counterpart in its lack of
hemagglutination activity (Glass et al., 1973), ability to
induce cell fusion (Bodelon et al., 2001, 2002; Shmulevitz
and Duncan, 2000), and association with naturally occurring
pathological conditions (Robertson and Wilcox, 1986). ARV
is an important cause of diseases in poultry. In particular,
reovirus-induced arthritis, chronic respiratory diseases, and05) 584–595
Fig. 1. Mapping of epitope II on jA recognized by monoclonal antibody
62. jA and its deletion fragments were expressed in E. coli BL21(DE3).
The fusion proteins were stained with Coomassie blue after SDS–PAGE (A)
and identified by Western blotting (B) and dot blot analysis (C) using MAb
62. Molecular weight markers (Bio-Rad) are shown in lane M. Lane 1, S2-
all; lane 2, S2D13; lane 3, S2D14; lane 4, S2D15; lane 5, S2D16; lane 6,
S2D17; lane 7, S2D18; lane 8, S2D19; lane 9, pET32a only. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 2. Mapping of epitope B on jNS recognized by monoclonal antibody
1F9. jNS and its deletion fragments were expressed in E. coli BL21(DE3).
The fusion proteins were stained with Coomassie blue after SDS–PAGE (A)
and detected by Western blotting (B) and dot blot analysis (C) using MAb
1F9. Molecular weight markers (Bio-Rad) are shown in lane M. Lane 1, S4-
all; lane 2, S4D1; lane 3, S4D13; lane 4, S4D14; lane 5, S4D20; lane 6,
S4D16; lane 7, S4D17; lane 8, S2D18; lane 9, pET32a only. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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voke considerable economic losses.
ARV-encoded proteins, including at least 10 structural
proteins (EA, EB, EC, AA, AB, ABC, ABN, jC, jA, and
jB), and 4 nonstructural proteins (ANS, P10, P17, and jNS)
have been demonstrated (Bodelon et al., 2001; Varela and
Benavente, 1994). Protein jC, encoded by the S1 gene
(Shapouri et al., 1995), shows noticeably higher divergence
than other j-class proteins (Liu et al., 2003) and is a cell
attachment protein (Martinez-Costas et al., 1997) and
apoptosis inducer (Shih et al., 2004). Protein jC is also the
target for type-specific neutralizing antibodies while anti-
bodies against jB are group-specific (Wickramasinghe et al.,
1993). Recently, ARV jA encoded by the S2 gene (Yin et al.,
2000) has been identified as a double-stranded RNA
(dsRNA) binding protein (Martinez-Costas et al., 2000;
Yin et al., 2000) and possible involvement in resistance to
interferon (Martinez-Costas et al., 2000). Another protein ofARV, jNS, encoded by the S4 gene (Chiu and Lee, 1997),
has been reported for its single-stranded RNA (ssRNA)
binding activity (Yin and Lee, 1998). We have previously
shown that two epitopes on jA (I and II) and three epitopes
(A, B, and C) on jNS (Hou et al., 2001; Pai et al., 2003). As
part of our work to characterize epitopes on jA and jNS
proteins of ARV, we further extended our past studies (Hou
et al., 2001; Pai et al., 2003). In this communication, we first
defined the locations of two epitopes on jA and jNS
proteins and analyzed their biological function using
monoclonal antibodies, Escherichia coli-expressed deletion
fragments of jA and jNS, synthetic peptides, the binding
assay of MAbs to heterologous ARV strains, and gel shift
assay.
P.H. Huang et al. / Virology 332 (2005) 584–595586Results and discussion
Expression and identification of rA and rNS proteins
The full-length jA- and jNS-encoding cDNAs of the
expression plasmid constructs were successfully overex-
pressed in E. coli. Each plasmid DNAwas introduced into E.
coli strain BL21 (DE3), and the protein extracts of the
induced recombinant cells were analyzed by 10% SDS–
PAGE. Protein bands were subsequently visualized by
Coomassie brilliant blue staining. Analysis of transformed
and expression-induced bacteria by SDS–PAGE revealed the
expressedjA and jNS fusion proteins withmolecular weight
of 64.75 kDa (Fig. 1A) and 60.24 kDa (Fig. 2A), respectively,Table 1
Primers used for the construction of the full-length and deletion fragments of jAwhich were consistent with the expected size of the fusion
proteins. The purified fusion protein and protein extracts of
the induced recombinant cells were then analyzed byWestern
blotting and dot blot assays with MAbs.
Monoclonal antibodies are useful for analyzing antigenic
properties of viruses. The recognition of expressed jA and
jNS proteins by MAbs 62, 1F9, H1E1, and 4A123,
respectively, was analyzed by Western blotting and dot blot
assays. Three MAbs 62, 1F9, and H1E1 were reactive in
Western blotting and dot blot assays (Figs. 1B–C and 2B–C)
when MAb 4A123 showed reactivity to jNS only in dot
blot assays (Table 2B). These results indicated that epitopes,
which were recognized by MAbs (62, 1F9, and H1E1)
following denaturation by, for instance, SDS–PAGE and- and jNS-encoding genes
a Underline indicates restriction sites (EcoRI and HindIII) introduced in each primer.
b Box indicates stop codons.
Table 1 (continued)
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reactivity of MAb 4A123 recognizing the epitope A on
jNS was fully abolished by denaturation, suggesting that
MAb 4A123 recognized a conformation-dependent epitope
of which at least one disulfide bond is essential to maintain
the three-dimensional integrity of the epitope. To map this
epitope, specific procedures to increase binding of MAbs to
conformation-dependent epitopes following Western blot-
ting are required (Dunn, 1986). In addition, we had tested
other MAbs from each of our previously-established
competitive groups, with the exception of MAb H1E1
which was the only monoclonal antibody against epitope C
on the jNS of ARV (Hou et al., 2001). The results were in
agreement with our previous investigations.Epitope mapping of anti-rA and -rNS monoclonal
antibodies by reaction with deletion mutants of rA and rNS
To localize the epitopes II and B on jA and jNS
proteins, respectively, a series of amino- and carboxy-
terminal-deleted fragments of the jA- and jNS-encoding
genes of S1133 strain were synthesized by PCR and
subcloned into pET expression vectors to construct a series
of expression constructs (Tables 1A–1B). Each plasmid
was introduced into E. coli strain BL21 (DE3), and the
protein extracts of the induced recombinant cells were
analyzed by 10% SDS–PAGE. The series of truncated jA-
and jNS-encoding genes were efficiently expressed in E.
coli strain BL21 (DE3) and could be visualized by
Table 2A
The antibody reactivity of the complete and truncated jA proteins with
MAb 62 in Western blotting and dot blot assays
Constructs Monoclonal antibody 62
Amino acid residue positions DB* WB*
S2-all 1–417 + +
S2D9 1–63  
S2D8 1–127  
S2D7 1–147  
S2D2 1–226  
S2D1 221–417 + +
S2D3 247–417 + +
S2D4 297–417 + +
S2D5 336–417 + +
S2D13 343–417 +/ +/
S2D14 346–417  
S2D15 349–417  
S2D10 352–417  
S2D6 366–417  
S2D12 297–345  
S2D11 297–349  
S2D16 297–360 + +
S2D17 297–365 + +
S2D18 297–368 + +
S2D19 297–371 + +
+, strong reactions; , no reactions.
* WB, Western blotting; DB, dot blotting.
Table 2B
The antibody reactivity of the complete and truncated jNS proteins with
MAbs 1F9 and H1E1, and 4A123 in Western blotting and dot blot assays
Constructs Monoclonal antibodies 1F9/H1E1 4A123
Amino acid residue
positions
DB* WB* DB* WB*
S4-all 1–367 + + + 
S4D9 1–29    
S4D8 1–61    
S4D7 1–93    
S4D2 1–183    
S4D20 1–194 + +  
S4D16 1–198 + +  
S4D17 1–201 + +  
S4D18 1–205 + +  
S4D19 1–211 + +  
S4D12 91–270 + +  
S4D1 178–367 + +  
S4D13 182–367 +/ +/  
S4D14 186–367    
S4D15 189–367    
S4D10 191–367    
S4D11 201–367    
S4D3 210–367    
S4D4 263–367    
S4D5 296–367    
S4D6 330–367    
S4D6 330–367    
+, strong reactions; +/, weak reactions; , no reactions.
* WB, Western blotting; DB, dot blotting.
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expressing S2D1, S2D2, S2D3, S4D2, S4D16, S4D17,
S4D18, and S4D19 were disrupted and the resulting extract
was centrifuged, the expressed proteins could not be
detected in the supernatant fraction, but it appears in the
pellet fraction, suggesting that these expressed proteins
were assembled into inclusion bodies. Proteins were
solubilized from pelleted inclusion bodies by incubation
with a buffer containing 8 M urea, and the expressed
proteins were subsequently purified by affinity chromatog-
raphy using Ni-NTA spin columns. With the exception of
the deletion fragments of S2D6, S2D18, S4D7, and S4D8,
which showed a low level of expression in E. coli, protein
purification resulted in approximately 80–90% pure dele-
tion fragments of jA and jNS, demonstrated by SDS–
PAGE and Coomassie blue staining. To determine the
nature of the epitopes, antibody reactivity to antigen
subjected to SDS–PAGE, Western blotting, and dot blot
assays was used for discrimination of linear from non-
linear epitopes. In the present study, the recognition of
recombinant deletion fragments of jA and jNS by MAbs
62, 1F9, H1E1, and 4A123 was analyzed, and the results
are summarized in Tables 2A and 2B.
For further location of epitope II on ARV jA, Western
blotting and dot blot assays of the amino- and carboxyl-
terminal-deleted mutants using MAb 62 showed that the
S4-all, S2D5, S2D16, S2D17, S2D18, and S2D19 retained
the full binding activity to the antibody, while S2D13 and
S2D14 almost lost its binding activity (Figs. 1B–C and
Table 2A). In Western blotting, other visible bands with
higher or lower molecular weight were also recognized.These could be protein molecules in samples that were not
well dissociated and were probably generated as a result of
the degradation of the fusion proteins. The results from
deletion analysis and the cross-reactivity of MAb 62 to
heterologous ARV variants indicated that the region of jA
for interaction with MAb 62 was located at amino acid
residues 336–360. Because the region of epitope mapped
by subtractive analyses was too large to be a linear
epitope, the synthetic peptides were used to confirm and to
reduce the boundary of epitope. In synthetic peptide assay,
MAb 62 can recognize three synthetic peptides (jA-1, jA-
2, and jA-3) (Table 3). Based upon a combination of
deletion mapping and reactivity of synthetic peptides with
MAb 62, we further defined epitope II on jA to be
340QWVMAGLVSAA350 (Fig. 3A). Our previous study
suggested that the reactivity of MAbs against epitope I on
jA was fully abolished after denaturation on jA protein
and that this epitope was conformation-dependent (Pai et
al., 2003). As mentioned above, the mapping of con-
formation-dependent epitopes needed specific procedures
to increase binding of MAbs to conformation-dependent
epitopes. Therefore, we did not attempt to map this
conformation-dependent epitope on jA because the meth-
ods used in this study were not capable of mapping this
epitope.
To define the epitope B on jNS, a series of truncated
recombinant proteins of the jNS were expressed and
Table 3
The synthetic peptides for epitope mapping
Label Sequence Epitope/protein Monoclonal antibodya
62 1F9/H1E1
jA-1 338IRQWVMAGLVSAAKG352 II/jA +b *c
jA-2 340QWVMAGLVSAAK351 II/jA + *
jA-3 340QWVMAGLVSAA350d II/jA + *
jNS-1 178PYMLDMVDGRPQIVL192 B/jNS * +
jNS-2 180MLDMVDGRPQI190 B/jNS * +
jNS-3 180MLDMVDGRPQ189 B/jNS * +
jNS-4 180MLDMVDGRP188e B/jNS * +
jNS-5 179YMLDMVDGRPQ189 B/jNS * +
jNS-6 179YMLDMVDGRP188 B/jNS * +
a Reactivity of monoclonal antibodies with each synthetic peptide in dot blot assay.
b Strong reaction.
c Not determined.
d The minimum region for epitope II.
e The minimum region for epitope B.
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fragments of jNS using MAbs1F9 and H1E1showed that
the S4-all, S4D1, S4D16, S4D17, and S4D20 retained full
binding activity to the antibody, while S4D13 S4D14, and
S4D11 showed weak or no binding activity to the antibody
(Figs. 2B–C and Table 2B). The results from deletion
analysis and the reactivity of heterologous virus strains with
MAbs 1F9 and H1E1 suggested that the region of jNS for
interaction with MAbs 1F9 and H1E1 was located at amino
acid residues 178–194. The epitopes mapped above by
deletion mapping using reactivity with the expressed protein
fragments seem relatively large for linear epitopes. To
further confirm epitope locations and to reduce the
boundary of the epitope, the synthetic peptides related to
these epitopes were used in dot blot assay. Monoclonal
antibodies 1F9 and H1E1 can recognize six synthetic
peptides (jNS-1, jNS-2, and jNS-3, jNS-4, jNS-5, and
jA-6) tested in this study (Table 3). Based upon a
combination of deletion mapping and reactivity of synthetic
peptide with monoclonal antibody, we further defined
epitope B on the jNS to be 180MLDMVDGRP188 (Fig.
3B). The present results indicated that both MAbs 1F9 and
H1E1 recognized the same epitope. It seems to be contra-
dictive to our previous report that MAbs 1F9 and 1E1
recognized different epitopes B and C on jNS, respectively,
based on competitive binding assay (Hou et al., 2001). In
fact, when the competition was rated as significant if it was
25% (or even 30%) to 60% rather than 35% to 60% (Hou et
al., 2001) to define epitope groups, the epitopes B and C
could be grouped into the same epitope recognized by the
MAbs 1F9 and H1E1.
The conformation-dependent epitope A on NS was not
possible to map since no binding to jNS deletion fragments
could be detected (Table 2B). However, a few studies have
recently detected non-linear epitopes by the use of Pepscan
techniques based on peptides coupled to cellulose mem-
branes (Korth et al., 1997; Reineke et al., 1995, 1998) or to
Immobilon (Gao and Esnouf, 1996).Amino acid sequence analysis
The results of the Jameson–Wolf antigenicity index and
sequence analysis indicated that 15 regions with a theoretical
Jameson–Wolf antigenicity index of 1.5 or more were
identified within the jA amino acid sequence of the S1133
virus strain and 9 regions were identified within the jNS
amino acid sequence. Results indicated that epitope II has
high antigenicity and hydrophilicity, while epitope B possess
high antigenicity and low hydrophilicity. Sequence analysis
of ARV jA revealed that jA appeared to contain a carboxyl
terminal region (one-fourth of the protein) that contains a-
helices and h-turns and a large amino-terminal region (three-
fourth of the protein) that is mainly h-turns and h-strands.
These results are similar to those for MRV j2 described
previously (Dermody et al., 1991), suggesting that both jA
and j2 proteins may have similar functions. Sequence
analysis of ARV jNS revealed that jNS appeared to contain
a carboxyl-terminal region that contains a-helices and a large
amino-terminal region that is mainly h-turns and h-sheets.
Variations resulting in evolutionary changes are both a
consequence of modifications in the genome and the result of
environmental pressures placed on the virus. Factors
determining genetic variability of ARV include point
mutations and genetic reassortment (Liu et al., 2003; Ni
and Kemp, 1995). However, RNA viruses which lack
proofreading and postreplicative error correction mecha-
nisms are expected to have a high mutation rate and therefore
to evolve rapidly (Steinhauer and Holland, 1987). Therefore,
it was interesting to know whether sequence variations of
epitopes among heterologous ARV strains occurred. In the
present study, the regions of amino acid 340–350 of jA and
aa 180–188 of jNS among 13 ARV strains, related to the
regions of epitopes II and B, were compared (Figs. 3A and
3B). Sequence analysis showed that only two amino acid
substitutions at position 343 (from methionine to valine) and
position 345 (from glycine to valine) were found in jA (Fig.
3A), while four amino acid substitutions at position 180
Fig. 3. Sequence comparison of epitope II on jA (A) and epitope B on jNS
(B) of ARV strains. ARV S1133 sequences were shown on top and the
differences were indicated. Reactivity of each virus strain with monoclonal
antibodies in ELISA assays was shown at the right hand side. Strong and
weak reactions were indicated by (+) and (+/), respectively.
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valine), 184 (from valine to isoleucine), and 185 (from
aspartic acid to asparagine) occurred in jNS among ARV
strains (Fig. 3B). The results indicated that the type of amino
acid changes in epitopes showed no correlation with either
serotypes or pathotypes of ARV.
Antibody binding assay
Since the region related to epitope II on jA protein of
Taiwanese strains showed sequence variation only at
positions 343 (from M to V) and 345 (from G to V), we
examined the importance of the residue in antibody binding.
In the binding of MAb 62 to heterologous virus strains, it
was found that MAb 62 recognized all tested strains which
belonged to different serotypes (Fig. 3A), suggesting that
the two-valine substitutions did not affect the reactivity of
epitope II and that the residues were not critical in antibodybinding. MAb 62 reacted with all heterologous ARV strains,
suggesting that this epitope is commonly shared by the ARV
strains. Recently, we developed an antigen capture enzyme-
linked immunosorbent assay (ELISA) using MAbs prepared
against the epitope II on jA synthesized in E. coli,
demonstrating that the MAb-based ELISA is a useful
method for the detection of ARV from chickens suspected
to have ARV infections (Pai et al., 2003). Taken together, all
the data indicated that epitope II is a good marker of ARV
infection that could be used for the detection of ARV
antibody response.
It was of particular interest to determine whether amino
acid changes on epitope B of jNS could hinder antibody
binding. Since the epitope B of jNS showed sequence
variations at positions 180, 183, 184, and185, the
importance of residue substitutions in antibody binding
was examined. To test the binding abilities of MAb1F9 to
heterologous ARV strains, the antibody was used to test for
their cross-reactivity with other ARV strains in ELISA.
With the exception of the 601G strain of ARV containing a
substitution at amino acid residue 183 (M to V), which
showed weaker reactivity (Fig. 3B), MAb 1F9 reacted with
all heterologous ARV strains. These observations sug-
gested that amino acid changes at 180 (M to T), 183 (M to
V), 184 (V to I), and 185 (D to N), did not affect the
binding activity of epitope B with MAb 1F9, but
substitution at an amino acid residue 183 (M to V) could
hinder the binding activity of epitope B (Fig. 3B).
Blocking of ssRNA binding activity of rNS and truncation
mutants with MAb 1F9 as well as gel shift assay of the rNS
and truncation mutants binding to ssRNA
To date, the region of ARV jNS which is responsible for
ssRNA binding has not been defined. To further determine
if the epitope B of jNS is involved in ssRNA binding,
preparation of deleted mutant proteins of jNS along with
gel shift assay was performed. It has been described for
several viruses that the ssRNA-protein binding activity is
important in genome assortment and initial stage of
replication (Antczak and Joklik, 1992; Patton, 1995).
Previous investigations suggested that jNS of MRV plays
an important role in mRNA assortment and packaging
because of its ssRNA-binding activity (Huisman and Joklik,
1976). In blocking assay, MAb 1F9 recognizing epitope B
was used to block ssRNA binding activity of jNS and
deletion mutants (S4 D1 and S4D2) that had been
preincubated with MAb 1F9, followed by poly (A)-
sepharose binding and bound protein analysis. The S4D2
mutant which did not possess epitope B showed no signals
in the blocking assay (Fig. 4B). The results showed that
MAb 1F9 at a dilution of 1:5 blocked binding of ssRNA to
jNS and S4 D1 (Figs. 4A–B), indicating that the inhibition
of 1F9 on the RNA binding of jNS could be a direct or
indirect effect on this activity. To further address this issue,
the gel shift assay of jNS and deletion fragments binding to
Fig. 5. Gel shift assay of jNS and truncation mutants (S4D2, S4D10,
S4D13, S4D18, and S4D19) binding to ssRNA. Autoradiographs of
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S4D13, S4D18, and S4D19 with epitope B had ssRNA
binding capacity while truncation fragments of S4D2 and
S4D10 without epitope B almost lost their ssRNA binding
capacity (Fig. 5). The results suggested that this epitope is
required for ssRNA binding of jNS because its deletion
fully abolished the ssRNA binding activity of jNS. In
addition, the full-length jNS that displayed the strongest
binding ability (Fig. 5, last lane) suggested that nature
conformation of jNS could be important for ssRNA
binding. The jNS mutants may lose some structure needed
for ssRNA binding and therefore showed weaker binding
ability than that of the full-length jNS of ARV. It is also
observed that S4D13 containing the C-terminal of jNS
showed much stronger ssRNA binding ability than that of
S4D18 and S4D19 that contain the N-terminal of jNS,
binding reactions after electrophoresis through a native polyacrylamide
gel are shown. Lane C represents the negative control.
Fig. 4. Blocking of ssRNA binding activity of jNS with MAb 1F9. (A)
Protein jNS was preincubated with monoclonal antibody at a dilution of
1:5 (lane 2) and 1:5000 (lane3). (B) Deletion fragments of S4D1 and S4D2
were preincubated with monoclonal antibody at a dilution of 1:5 (lane 2),
1:500 (lane 3), and 1:5000 (lane 4). Lane 1 represents the sample that
contains poly (A)-sepharose and jNS without antibody. The deletion
fragment of S4D2 which did not contain epitope B was used as a negative
control. The reaction mixtures were mixed with poly (A)-sepharose.
Proteins bound to poly (A) were separated by SDS–PAGE, electro-
transferred onto nitrocellulose membranes, and probed with MAb 1F9.suggesting that the C-terminal of jNS could be important
for ssRNA binding.
In the present study, the conservative characteristics of
epitope II on jA and epitope B on jNS seem to have
functional constraints against amino acid changes. To further
elucidate if these epitopes on jA and jNS of ARV have
other biological function would be worthwhile to obtain
more useful information concerning the roles of jA and jNS
proteins in genome assortment and virus replication.Materials and methods
Virus strains and RNA preparation
Thirteen ARV strains used in this study were described
previously (Lee et al., 1992). These ARV strains were
propagated in Vero cells. Upon development of 70–80%
cytopathic effect (CPE), the cell cultures were frozen and
stored at 70 8C. Viral particles were purified following
methods described previously (Liu et al., 1999, 2002, 2004).
Purified viral particles were resuspended in TNE buffer
containing 5% sodium dodecyl sulfate (SDS). Proteinase K
was added to a final concentration of 1 mg/ml. After
incubation for 1 h at 37 8C, the viral RNA was isolated by
two consecutive phenol/chloroform/isoamyl alcohol
(25:24:1) extractions and recovered by precipitation with
ethanol containing 0.4 M LiCl. The dsRNA was further
purified by LiCl fractionation precipitation (Diaz-Ruiz and
Kaper, 1978). Viral RNA was washed twice with 70%
ethanol to remove LiCl and suspended in diethylpyrocar-
bonate (DEPC)-treated water.
Monoclonal antibodies
The jA-specific MAb (62) and jNS-specific MAbs
(1F9, H1E1, and 4A123) against the S1133 strain of ARV
P.H. Huang et al. / Virology 332 (2005) 584–595592were described previously (Hou et al., 2001; Pai et al.,
2003). These particular MAbs used in this study were based
on the higher concentration of immunoglobulin secreted by
the hybridoma cell lines (62, 1F9, H1E1, and 4A123).
Reverse transcription (RT)-polymerase chain reaction
(PCR)
To determine the S2 and S4 gene nucleotide sequences
of thirteen ARV strains, purified genomic dsRNA was
used to generate the full-length cDNA clones by reverse
transcription and polymerase chain reaction amplification
(RT-PCR). The sequences and locations of primers used
to generate the full-length and deletion fragments of S2
and S4 genes of S1133 strain of ARV are indicated in
Tables 1A–1B. The primers for amplification of the full-
length jA- and jNS-encoding genes were located at the 5V
and 3V noncoding regions encompassing the jA and jNS
open reading frame (ORF). The primers for construction
of the deleted fragments of jA- and jNS-encoding genes
were located at regions with a low Jameson–Wolf
antigenicity index and hydrophilicity. In RT-PCR test, 1
Ag of purified dsRNA was denatured in boiling water for
10 min, chilled on ice for 5 min, and then used as a
template. RT-PCR reactions were carried out according to
procedures provided by Perkin-Elmer Co. (Branchburg,
NJ, USA). Reverse transcription (RT) was carried at 50
8C for 30 min. PCR reactions were subjected to 35 cycles
consisting of denaturation for 1 min at 94 8C,
annealing for 1 min at 55 8C, and extension for 90 s at 72
8C. An additional 7 min at 72 8C was included at the end
of the program to ensure complete extension. After
completion of PCR, 5 Al of reaction mixture was loaded
onto a 1.5% agarose gel, containing 5 Ag/ml ethidium
bromide, for electrophoresis and subsequent visualization
by UV transillumination.
Gene expression and protein purification
The full-length jA- and jNS-encoding genes of S1133
strain were cloned into pET32 expression vectors (Nova-
gen, Madison, WI, USA). PCR products (1275 bp) from
the jA-encoding gene were treated with Klenow polymer-
ase and inserted into the SmaI site of pET32a expression
vector. PCR products (1152 bp) derived from the jNS-
encoding gene were digested with EcoRI and then ligated
into the corresponding site of a pET32b bacterial expres-
sion vector. Recombinant plasmids were used to transform
E. coli-competent cells (DE3). DNA minipreps using an
alkaline lysis method were performed on white colonies
suspected of containing an insert. Colonies with correct
sizes were further identified by restriction enzyme analysis.
Recombinant plasmid DNA was purified using a purifica-
tion kit (Qiagen, Valencia, CA, USA) prior to sequencing.
In order to assure that the sequences did not contain PCR-
based errors, three clones of each gene were sequencedwith an Automated Laser Fluorescence DNA Sequencer
(ABI).
The procedures for jA and jNS expression in E. coli
have been described previously (Liu et al., 2002; Yin and
Lee, 1998; Yin et al., 2000). Briefly, after induction for 3 h
with isopropyl-h-d-thiogalactopyranoside (IPTG) at a final
concentration of 0.4 mM in culture medium, E. coli cells
containing pET32a-jA and pET32b-jNS were induced, and
the cell pellets were harvested by centrifugation (5000 rpm
for 5 min), resuspended in TE buffer (50 mM Tris–HCl, pH
8.0; 2 mM EDTA) containing 0.1% Triton X-100 and 100
Ag/ml chicken egg-white lysozyme (Sigma), and then
incubated on ice for 15 min. To obtain soluble or insoluble
fusion proteins, whole cell pellets from bacterial cultures
were disrupted by sonication at 4 8C. The expressed proteins
were subsequently purified by affinity chromatography
using Ni-NTA spin columns (Qiagen, Valencia, CA,
USA). The protein concentration was determined according
to the Lowry method (Lowry et al., 1951). The supernatant
or pelleted insoluble materials were separated on 10%
acrylamide gels.
To generate the deletion fragments of jA and jNS of
S1133 strain, a series of amino- or carboxy-terminal deletion
mutants of the jA- and jNS-encoding genes synthesized by
PCR were subcloned into pET expression vectors to
construct a series of expression constructs (Tables 1A–B).
The expression and purification of the truncated jA and
jNS fragments were performed by the procedures described
above.
SDS–PAGE, Western blotting, and dot blot assay
To localize the epitopes on jA and jNS of S1133 strain,
SDS–PAGE, Western blotting, and dot blot analysis were
performed. Purified jA, jNS, and a series of truncated jA
and jNS fusion proteins and protein extracts of the induced
recombinant cells were mixed with an equal volume of
reducing Laemmli sample buffer, boiled for 3 min, and
separated by SDS–PAGE. The gels were stained by standard
methods using Coomassie brilliant blue or electroblotted
onto nitrocellulose (NC) membranes (Towbin et al., 1979).
Following post-coating of the NC membranes with 5% dry
milk in phosphate-buffered saline, pH 7.4, with 0.05%
Tween 20 (PBST) for 30 min at room temperature, the NC
membranes were probed with a 1:200 dilution of mono-
clonal antibodies followed by reaction with HRP-conju-
gated goat anti-mouse immunoglobulin. The binding
reaction was detected by the addition of the diaminobenzi-
dine color development reagent (0.05% diaminobenzidine,
0.005% hydrogen peroxide in distilled water).
To determine the need for a native structure for antibody
binding, an immuno-dot binding assay was performed. In
dot blot assays, purified jA, jNS, and a series of truncated
jA and jNS fusion proteins were dotted onto NC
membranes and air dried for 30 min. Following post-coating
of the NC membranes with 5% dry milk in PBST for 30 min
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MAbs. HRP conjugate incubation and color development
were performed as described for Western blotting.
Sequence analysis
To analyze the sequence variations of epitopes on jA
and jNS, the Kyte–Doolittle hydrophilic plot and Jameson–
Wolf antigenicity index analysis were performed using
DNASTAR package software (DNASTAR, Madison, WI,
USA). Amino acid sequences of these epitopes among ARV
strains were compared using the same program described
above. The sequences of jA and jNS of ARV were
reported by our laboratory (Liu and Huang, 2001; Liu et al.,
2003). Accession numbers for the jA- and jNS-encoding
genes were as follows: 1733-jA, AF293773; 2408-jA,
AF247724; OS161-jA, AF294770; 601SI-jA, AF294769;
T6-jA, AF294768; 750505-jA, AF294767; 919-jA,
AF294763; 601G-jA, AF311322; R2/TW-jA, AF294765;
918-jA, AF294766; 916-jA, AF294764; 1017-1-jA,
AF294762; 1733-jNS, AF294722; 2408-jNS, AF213468;
OS161-jNS, AF294777; 601SI-jNS, AF294773; T6-jNS,
AF213469; 750505-jNS, AF213470; 919-jNS, AF294776;
601G-jNS, AF311322; R2/TW-jNS, AF294778; 918-jNS,
AF294775; 916-jNS, AF294774; and 1017-1-jNS,
AF294771. Accession numbers for other sequences were
as follows: S1133-jA, AF104311 and S1133-jNS, U95952.
Synthetic peptide
Synthetic peptides have been a useful means for
epitope mapping as described previously (Dietzschold et
al., 1987; Goto et al., 2000). To further confirm the
epitopes identified by deletion mapping method were real
and not artifacts, the consecutive overlapping peptides
were designed to mimic and cover the entire region of
epitopes mapped by the subtractive analyses of deletion
mapping. Synthetic peptides (Table 3) were synthesized
and used in dot blot assay.
Cross-reactivity of MAbs to heterologous ARV strains
The procedures for cross-reactivity of the MAbs to
heterologous ARV strains have been described previously
(Hou et al., 2001; Pai et al., 2003). Briefly, to study the
monoclonal antibodies (62 and 1F9) for their cross-reactivity
with various ARV strains in an antigen-captured enzyme-
linked immunosorbent assay (ELISA), a volume of 100 Al
(1:200) of mouse anti-jA and -jNS antiserum was coated
onto ELISA plates. After washing and blocking with 2%
bovine serum albumin, 100 Al of cell extracts (30 moi) from
Vero cells infected with each ARV strain or from mock-
infected cells was added and incubated at 37 8C for 1 h. For
the binding assay of MAbs with various ARV strains, 50 Al of
HRP-conjugated MAbs 62 and 1F9 was added as primary
antibodies. To determine if jA and jNS proteins present ineach cell extract from Vero cells infected with each ARV
strain were captured by anti-jA and -jNS antiserum,
respectively, a 1:200 dilution of chicken anti-ARV S1133
hyperimmune serum and HRP-coupled goat anti-chicken
antiserum (1:2000) was used as primary and secondary
antibodies, respectively. Absorbance was measured at 405
nm. Binding to the heterologous virus is expressed as
percentage by taking the absorbance obtained with ARV
S1133 in the reaction as 100. The relative binding activity to
heterologous ARV isolates was rated as described previously
(Hou et al., 2001; Pai et al., 2003).
Binding of protein rNS and truncation mutants to
poly (A)-sepharose in the presence of MAb 1F9
To determine if the epitopes of jNS were involved in
ssRNA binding, in the initial experiments various concen-
trations of MAb 1F9 were used to test the blocking
activities of binding of jNS to ssRNA probes in gel shift
analysis (Richmond et al., 1998) or Northwestern blot
(Dermody et al., 1991). In blocking assay, purified jNS (5
Ag) and two deletion mutants (S4D1 and S4D2) were
incubated with various dilutions of MAb 1F9 in a total
volume of 10 Al at 37 8C for 1 h. The reaction mixtures
and poly (A)-sepharose (Pharmacia) containing 55 Ag
poly(A) oligomer were combined with a binding buffer
(150 mM NaCl, 1 mM DTT, 0.5% Tween 20, 20 mM
Hepes, 5 mM MgOAc, 10% glycerol, pH 7.4) for a total
volume of 150 Al and incubated at 25 8C for 15 min.
After four washes with binding buffer, proteins bound to
the poly (A)-sepharose were eluted with binding buffer
containing 1 M NaCl. Eluted proteins were separated by
SDS–PAGE and electrotransferred onto nitrocellulose
membrane. The nature of jNS protein and deletion
mutants (S4D1 and S4D2) immobilized on the membrane
was detected by using a conformation-independent MAb
1F9 as probe.
Gel shift assay of protein jNS and truncation mutants
binding to ssRNA
In gel shift assay, purified jNS protein (S4-all) and five
deletion mutants and 32P-radiolabeled ssRNA probes (104 to
105 cpm) were combined with a binding reaction buffer (150
mMNaCl, 1 mMDTT, 0.5% Tween 20, 20mMHepes, 5 mM
MgOAc, 10% glycerol, pH 7.4) for a total volume of 15 Al
and incubated at 30 8C for 15 min (Yin et al., 1997). The 32p-
radiolabeled virus-specific ssRNA probe by run-off tran-
scription was prepared as described previously (Yin and Lee,
1998). The reaction mixtures were then separated by
electrophoresis on 6% polyacrylamide nondenaturing gels
(Konarska and Sharp, 1987) and subjected to autoradiog-
raphy for 16–18 h. To ensure that the 16 kDa peptide which
was fused to jNS did not affect the RNA-protein binding, the
purified jNS and deleted mutants were treated with
enterokinase.
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